je.st
news
Amgen cholesterol drug appears safe, cut LDL 52 percent at 1 year: study
2013-11-20 13:55:40| Biotech - Topix.net
Amgen Inc's experimental heart medicine from a closely watched new class of drugs called PCSK9 inhibitors lowered "bad" LDL cholesterol 52 percent after one year with no major increase in serious adverse side effects compared with standard drugs, such as statins, according to data from a study.
Tags: year
study
safe
cut
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||